Clinical Trial Update: Evaluation of Prime-boost Anti-pneumococcal Vaccination in Patients With Diffuse Large B Cell Lymphoma Treated With Rituximab [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a prime-boost anti-pneumococcal vaccination strategy in patients with diffuse large B-cell lymphoma treated with rituximab h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Pneumococcal Infections

Drugs mentioned

• Prime-boost Anti-pneumococcal Vaccination
• Rituximab (rituximab)

Snippet

Sponsor: University Hospital, Tours | Conditions: Pneumococcal Infections, Lymphoma, Large B-Cell, Diffuse | Phase 3 | Status: COMPLETED